Abstract | OBJECTIVE: METHODS: BALB/c mice were treated with zidovudine or zalcitabine. Some of the mice were cotreated with mitocnol, a dietary supplement with high uridine bioavailability. Mice hind limb muscles were examined after 10 weeks. RESULTS: CONCLUSION:
|
Authors | Dirk Lebrecht, Catherine Deveaud, Bertrand Beauvoit, Jacques Bonnet, Janbernd Kirschner, Ulrich A Walker |
Journal | Arthritis and rheumatism
(Arthritis Rheum)
Vol. 58
Issue 1
Pg. 318-26
(Jan 2008)
ISSN: 0004-3591 [Print] United States |
PMID | 18163507
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA, Mitochondrial
- Lactates
- Reverse Transcriptase Inhibitors
- Triglycerides
- Zidovudine
- Malondialdehyde
- Zalcitabine
- Electron Transport Complex IV
- Uridine
|
Topics |
- Animals
- DNA, Mitochondrial
(metabolism)
- Drug Interactions
- Electron Transport
(drug effects)
- Electron Transport Complex IV
(metabolism)
- Gene Dosage
- Lactates
(blood)
- Lipid Peroxidation
(drug effects)
- Male
- Malondialdehyde
(metabolism)
- Mice
- Mice, Inbred BALB C
- Mitochondrial Myopathies
(chemically induced, pathology, prevention & control)
- Muscle, Skeletal
(pathology)
- Reverse Transcriptase Inhibitors
(toxicity)
- Triglycerides
(metabolism)
- Uridine
(pharmacology)
- Zalcitabine
(toxicity)
- Zidovudine
(toxicity)
|